Literature DB >> 23886190

Surgical treatment for early esophageal squamous cell carcinoma.

Shao-Bin Chen1, Hong-Rui Weng, Geng Wang, Jie-Sheng Yang, Wei-Ping Yang, Di-Tian Liu, Yu-Ping Chen, Hao Zhang.   

Abstract

More studies are needed to clarify treatments and prognosis of early esophageal squamous cell carcinoma (ESCC). This retrospective study was designed to review the outcome of surgical treatment for early ESCC, evaluate the results of a left thoracotomy for selected patients with early ESCC, and identify factors affecting lymph node metastases and survival. The clinicopathological data of 228 patients with early ESCC who underwent transthoracic esophagectomy with lymphadenectomy without preoperative adjuvant treatment were reviewed. The χ(2) test or Fisher's exact test were used to detect factors related to lymph node metastasis. Univariate and multivariate analyses were performed to identify prognostic factors. There were 152 males and 76 females with a median age of 55 years. Two hundred and eight patients underwent a left thoracotomy, and the remaining 20 patients with lymph nodes in the upper mediastinum more than 5 mm in short-axis diameter by computed tomography scan underwent a right thoracotomy. No lymph node metastasis was found in the 18 patients with carcinoma in situ, while lymph node metastases were detected in 1.6% (1/62) of patients with mucosal tumours and 18.2% (27/148) of patients with submucosal tumours. Only 7 patients showed upper mediastinal lymph node metastases in the follow-up. The 5- and 10-year overall survival rates were 81.4% and 70.1%, respectively. Only histologic grade (P<0.001) and pT category (P=0.001) significantly correlated with the presence of lymph node metastases. In multivariate analysis, only histologic grade (P=0.026) and pT category (P=0.008) were independent prognostic factors. A left thoracotomy is acceptable for selected patients with early ESCC. Histologic grade and pT category affected the presence of lymph node metastases and were independent prognostic factors for early ESCC.

Entities:  

Mesh:

Year:  2013        PMID: 23886190     DOI: 10.7314/apjcp.2013.14.6.3825

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Expression and function of tetraspanin 1 in esophageal carcinoma.

Authors:  Tingting Gu; Weiwei Chen; Li Chen; Guilan Wang; Tiejun Li; Yuanyuan Zhu; Xiaojiao Gao
Journal:  Oncol Lett       Date:  2017-09-22       Impact factor: 2.967

2.  Oncological and surgical outcomes of minimally invasive versus open esophagectomy for esophageal squamous cell carcinoma: a matched-pair comparative study.

Authors:  Wenli Wang; Yongxin Zhou; Jing Feng; Yunqing Mei
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Comparison of Ivor Lewis and Sweet esophagectomy for middle and lower esophageal squamous cell carcinoma: A systematic review and pooled analysis.

Authors:  Yuhang Xue; Donglai Chen; Wei Wang; Wenjia Wang; Lei Chen; Yonghua Sang; Yongbing Chen; Weihua Xu
Journal:  EClinicalMedicine       Date:  2020-10-10

4.  Comparison of Ivor Lewis esophagectomy and Sweet esophagectomy for the treatment of middle-lower esophageal squamous cell carcinoma.

Authors:  Yuan Feng; Nan Wu; Shi Yan; Xing Wang; Yue Yang
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

5.  Evaluation of safety profile of thoracoscopic esophagectomy for T1bN0M0 cancer using data from JCOG0502: a prospective multicenter study.

Authors:  Isao Nozaki; Ken Kato; Hiroyasu Igaki; Yoshinori Ito; Hiroyuki Daiko; Masahiko Yano; Harushi Udagawa; Junki Mizusawa; Hiroshi Katayama; Kenichi Nakamura; Yuko Kitagawa
Journal:  Surg Endosc       Date:  2015-02-13       Impact factor: 4.584

6.  Modeling the Cost-effectiveness of Esophageal Cancer Screening in China.

Authors:  Yuanyuan Li; Lingbin Du; Youqing Wang; Yuxuan Gu; Xuemei Zhen; Xiaoqian Hu; Xueshan Sun; Hengjin Dong
Journal:  Cost Eff Resour Alloc       Date:  2020-09-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.